{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:44:59Z","timestamp":1788993899502,"version":"build-2803163510"},"reference-count":113,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1699,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Plasma levels of fibrinogen have been identified as independent risk predictors of cardiovascular disease. This has greatly increased interest in the regulation of plasma fibrinogen levels. Many demographic and environmental factors are known to affect fibrinogen levels, such as diet, use of several drugs, age, smoking, body mass, gender, physical exercise, race, and season. Additionally, it is also known that genetic factors determine the fibrinogen levels, and also that they determine the response of fibrinogen levels to environmental factors. Estimates, based on twin studies, suggest that 30\u201350% of the plasma fibrinogen level is genetically determined. The effect of dietary components on plasma fibrinogen levels is modest. Several components have been identified as factors that influence fibrinogen levels. Among those are fish oil, other lipids, and fibers. Dietary components that were expected to have an effect on fibrinogen, but for which no association was observed are black and green tea. Several drugs are known to influence fibrinogen levels, the most studied of which are platelet aggregation inhibiting drugs, such as ticlopidine, and the lipid lowering fibric acid derivatives (fibrates). Both types of drugs decreased the plasma fibrinogen level by about 10%, and bezafibrate lowers fibrinogen even more in patients with diabetes. No clear effect was observed for the HMG\u2010CoA reductase inhibitors (statins). In the Bezalip study, fibrinogen levels decreased in patients treated with bezafibrate, but this had no clear effect on the risk of cardiovascular disease. This suggests that several mechanisms influence the fibrinogen level and that these mechanisms may contribute differently to cardiovascular disease. Several variations in the fibrinogen genes have been described and especially variations in the promoter region of the fibrinogen \u03b2\u2010gene are interesting, because the synthesis of the fibrinogen B\u03b2 chain is considered to be the rate limiting step in the fibrinogen biosynthesis. In many studies the fibrinogen \u03b2\u2010gene polymorphisms (\u2212455G\/A, \u2212148C\/T, and BclI) are found to be associated with the plasma levels of fibrinogen. However, they are not associated with the risk of cardiovascular events, although in several studies an association with the severity and progression of atherosclerosis has been reported. It has also been observed frequently that the fibrinogen \u03b2\u2010gene promoter polymorphisms are associated with the response of fibrinogen levels to environmental factors, such as exercise and trauma. In conclusion, plasma fibrinogen levels are regulated by an interesting and complex interplay between environmental and genetic factors.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb03537.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T18:57:51Z","timestamp":1279652271000},"page":"509-521","source":"Crossref","is-referenced-by-count":58,"title":["Effects of Diet, Drugs, and Genes on Plasma Fibrinogen Levels"],"prefix":"10.1111","volume":"936","author":[{"given":"MONIEK P.M.","family":"DE MAAT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90111-X"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X9700200207"},{"key":"e_1_2_7_4_2","first-page":"635","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris","volume":"332","author":"Thompson S.G.","year":"1995","journal-title":"European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group (see comments). N. Engl. J. Med."},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90137-6"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(82)90214-6"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656337"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"24259","DOI":"10.1016\/S0021-9258(18)35759-4","article-title":"The effect of fibrin structure on fibrinolysis","volume":"267","author":"Gabriel D.A.","year":"1992","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(92)90069-S"},{"key":"e_1_2_7_10_2","first-page":"780","article-title":"Determinants of plasma fibrinogen: relation to body weight, waist\u2010to\u2010hip ratio, smoking, alcohol, age, and sex","volume":"12","author":"Krobot K.","year":"1992","journal-title":"Results from the second MONICA Augsburg survey 1989\u20131990. Arterioscler. Thromb."},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92557-8"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92205-7"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.10.1559"},{"key":"e_1_2_7_14_2","first-page":"179","article-title":"On the identification of beneficial and detrimental molecular forms of fibrinogen","volume":"29","author":"Henschen\u2010Edman A.H.","year":"1999","journal-title":"H\u00e6mostasis."},{"key":"e_1_2_7_15_2","first-page":"22650","article-title":"Functional characterization of promoter elements involved in regulation of human B beta\u2010fibrinogen expression","volume":"268","author":"Anderson G.M.","year":"1993","journal-title":"Evidence for binding of novel activator and repressor proteins. J. Biol. Chem."},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1661276"},{"key":"e_1_2_7_17_2","article-title":"Influence of plasma triglyceride and plasma cholesterol levels on the clearance rate of fibrinogen","volume":"936","author":"Verschuur M.","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199801000-00005"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(94)05517-M"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04093.x"},{"key":"e_1_2_7_21_2","article-title":"Effect of moderate alcohol consumption on fibrinogen levels in healthy volunteers is discordant with effects on C\u2010Reactive Protein","volume":"936","author":"Sierksma A.","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"e_1_2_7_22_2","first-page":"410","article-title":"Diet, blood coagulation and fibrinolysis","volume":"42","author":"Marckmann P.","year":"1995","journal-title":"Dan. Med. Bull."},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)00880-1"},{"key":"e_1_2_7_24_2","first-page":"58","article-title":"Tea drinking and h\u00e6mostasis: a randomized, placebo\u2010controlled, crossover study in free\u2010living subjects","volume":"26","author":"Vorster H.","year":"1996","journal-title":"H\u00e6mostasis."},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601084"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(80)90108-5"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00910780"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199200208-00007"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.12.2.201"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90011-1"},{"key":"e_1_2_7_31_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ajcn\/59.1.115","article-title":"Lipid\u2010lowering diets enriched with monounsaturated or polyunsaturated fatty acids but low in saturated fatty acids have similar effects on serum lipid concentrations in hyperlipidemic patients","volume":"59","author":"Nydahl M.C.","year":"1994","journal-title":"Am. J. Clin. Nutr."},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.40.479"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.12.3449"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/65.5.1687S"},{"issue":"1","key":"e_1_2_7_35_2","first-page":"S85","article-title":"Fish consumption, omega\u20103 fatty acids and the Mediterranean diet","volume":"47","author":"Garcia Closas R.","year":"1993","journal-title":"Eur. J. Clin. Nutr."},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02536136"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(94)90017-5"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.13.8.1205"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/121.2.165"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.16.9.1156"},{"key":"e_1_2_7_41_2","first-page":"1040","article-title":"Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris","volume":"73","author":"Maat M.P.M.","year":"1995","journal-title":"Thromb. H\u00e6most."},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00050913"},{"key":"e_1_2_7_43_2","first-page":"968","article-title":"Lowering the plasma fibrinogen concentration with drugs","volume":"11","author":"Ernst E.","year":"1992","journal-title":"Clin. Pharm."},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(97)00091-1"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_A.47"},{"key":"e_1_2_7_46_2","first-page":"169","article-title":"Drugs affecting plasma fibrinogen levels","volume":"46","author":"Margaglione M.","year":"1996","journal-title":"Implications for new antithrombotic strategies. Prog. Drug Res."},{"key":"e_1_2_7_47_2","first-page":"17","article-title":"Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidaemia","volume":"5","author":"Maat M.P.M.","year":"1994","journal-title":"Blood Coagul. Fibrinol."},{"key":"e_1_2_7_48_2","first-page":"221","article-title":"Comparison of the effects of bezafibrate and acipimox on the lipid pattern and plasma fibrinogen in hyperlipidaemic type 2 (non\u2010insulin\u2010dependent) diabetic patients","volume":"18","author":"Niort G.","year":"1992","journal-title":"Diabete. Metab."},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79472-1"},{"issue":"1","key":"e_1_2_7_50_2","first-page":"S41","article-title":"Lowering fibrinogen levels: clinical update","volume":"10","author":"Behar S.","year":"1999","journal-title":"BIP Study Group. Bezafibrate Infarction Prevention. Blood Coagul. Fibrinol."},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.9.2991"},{"key":"e_1_2_7_52_2","first-page":"75","article-title":"Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidaemia","volume":"77","author":"Maat M.P.M.","year":"1997","journal-title":"Thromb. H\u00e6most."},{"key":"e_1_2_7_53_2","first-page":"1167","article-title":"Effects of gemfibrozil and ciprofibrate on plasma levels of tissue\u2010type plasminogen activator, plasminogen activator inhibitor\u20101 and fibrinogen in hyperlipidaemic patients","volume":"78","author":"Kockx M.","year":"1997","journal-title":"Thromb. H\u00e6most."},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00202863"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1996.tb02623.x"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.3.440"},{"key":"e_1_2_7_57_2","first-page":"915","article-title":"The role of beta\u2010fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden","volume":"70","author":"Green F.","year":"1993","journal-title":"Thromb. H\u00e6most."},{"key":"e_1_2_7_58_2","first-page":"805","article-title":"Fibrinogen plasma levels in an apparently healthy general population\u2014relation to environmental and genetic determinants","volume":"80","author":"Margaglione M.","year":"1998","journal-title":"Thromb. H\u00e6most."},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.13.6.886"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.4.621"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119499"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.3.487"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1517.005k48_1517_1532"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.2.265"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.12.3489"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.16.3.386"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(98)00143-1"},{"key":"e_1_2_7_68_2","first-page":"1120","article-title":"Positive association of the beta fibrinogen H1\/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction","volume":"77","author":"Gardemann A.","year":"1997","journal-title":"Thromb. H\u00e6most."},{"key":"e_1_2_7_69_2","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood.V92.9.3286","article-title":"Detection of a complex that associates with the B beta fibrinogen G(\u2212455)A polymorphism","volume":"92","author":"Brown E.T.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_70_2","first-page":"1224","article-title":"The effect of genetic variation in the \u03b2\u2010fibrinogen 5\u2032\u2010flanking region on nuclear protein binding, transcriptional activity and plasma fibrinogen level","volume":"73","author":"Green F.","year":"1995","journal-title":"Thromb. H\u00e6most."},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116495"},{"key":"e_1_2_7_72_2","article-title":"Effect of genetic background and diet on plasma fibrinogen in mice. Possible relation with susceptibility for atherosclerosis","volume":"936","author":"Rezaee F.","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"e_1_2_7_73_2","first-page":"1270","article-title":"Effect of intensive glycaemic control on fibrinogen plasma concentrations in patients with Type II diabetes mellitus","volume":"41","author":"Ceriello A.","year":"1998","journal-title":"Relation with beta-fibrinogen genotype. Diabetologia"},{"key":"e_1_2_7_74_2","doi-asserted-by":"crossref","unstructured":"Mercuri F. D. Fabbro R. Giacomello et al.1998. Effect of intensive glycemic control on fibrinogen plasma levels in diabetic subjects\u2014relationship with beta\u2010fibrinogen genotype. Molecular and Cell Biology of Type 2 Diabetes. 216.","DOI":"10.1159\/000060884"},{"key":"e_1_2_7_75_2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/ajcn\/68.3.568","article-title":"Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: the national heart, lung, and blood institute family heart study","volume":"68","author":"Djousse L.","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(93)90119-F"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(00)00197-3"},{"key":"e_1_2_7_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/128.2.198"},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_A.21"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199308000-00002"},{"key":"e_1_2_7_81_2","first-page":"197","article-title":"Nutritional determinants of h\u00e6mostatic factors in the Caerphily Study","volume":"42","author":"Rogers S.","year":"1988","journal-title":"Eur. J. Clin. Nutr."},{"key":"e_1_2_7_82_2","first-page":"490","article-title":"Prolonged very low calorie diet in highly obese subjects reduces plasma viscosity and red cell aggregation but not fibrinogen","volume":"18","author":"Poggi M.","year":"1994","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9120(92)80010-E"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.16.3.381"},{"key":"e_1_2_7_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0268-9499(90)90366-R"},{"key":"e_1_2_7_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01088096"},{"key":"e_1_2_7_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/58.3.354"},{"key":"e_1_2_7_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/67.2.255"},{"key":"e_1_2_7_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(97)00062-5"},{"key":"e_1_2_7_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(98)00170-4"},{"key":"e_1_2_7_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1992.tb00980.x"},{"key":"e_1_2_7_92_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199610000-00018"},{"key":"e_1_2_7_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00256-7"},{"key":"e_1_2_7_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(94)90251-8"},{"key":"e_1_2_7_95_2","first-page":"1437","article-title":"Lipid\u2010hemostasis interactions: a new approach to cardiovascular risk factors","volume":"27","author":"Chadarevian R.","year":"1998","journal-title":"Presse Med."},{"key":"e_1_2_7_96_2","first-page":"1","article-title":"Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects","volume":"10","author":"Hernandez\u2010Mijares A.","year":"2000","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"e_1_2_7_97_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615393"},{"key":"e_1_2_7_98_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199834020-00003"},{"key":"e_1_2_7_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00532-8"},{"key":"e_1_2_7_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199907000-00004"},{"key":"e_1_2_7_101_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199816030-00006"},{"key":"e_1_2_7_102_2","first-page":"455","article-title":"More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia","volume":"143","author":"Bertolotto A.","year":"1999","journal-title":"Atherosclerosis"},{"key":"e_1_2_7_103_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649476"},{"key":"e_1_2_7_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00018-2"},{"key":"e_1_2_7_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(94)90018-3"},{"key":"e_1_2_7_106_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00878936"},{"key":"e_1_2_7_107_2","first-page":"360","article-title":"Effect of medication with pravastatin sodium on hemorheological parameters in patients with hyperlipoproteinemia","volume":"12","author":"Tsuda Y.","year":"1993","journal-title":"Int. Angiol."},{"key":"e_1_2_7_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(95)05757-9"},{"key":"e_1_2_7_109_2","first-page":"829","article-title":"Hypercoagulable state in patients with hypercholesterolemia: effects of pravastatin","volume":"14","author":"Wada H.","year":"1992","journal-title":"Clin. Ther."},{"key":"e_1_2_7_110_2","first-page":"56","article-title":"The effect of stanozolol on thrombotic risk factors in healthy individuals","volume":"11","author":"Preston F.E.","year":"1982","journal-title":"H\u00e6mostasis."},{"key":"e_1_2_7_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb08676.x"},{"key":"e_1_2_7_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(94)90177-5"},{"key":"e_1_2_7_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00007-8"},{"key":"e_1_2_7_114_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.25.10.2017"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb03537.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03537.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:32:43Z","timestamp":1695619963000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb03537.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb03537.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03537.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}